NCT02113813 · Interventional trial
A Dose Escalation Study of ASP8273 in Subjects With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations
Overall registry status Completed
Phase 1
Conditions Epidermal Growth Factor Receptor Mutations, Non-Small-Cell Lung Cancer (NSCLC)
Delaware Valley sites
- Site US10009 · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory